Clinical Trials Directory

Trials / Completed

CompletedNCT00526019

Persistence of Airway Inflammation and Remodeling in Subjects With Symptomatic or Complete Asthma Remission

Characteristics of Symptomatic Asthma Remissions

Status
Completed
Phase
Study type
Observational
Enrollment
85 (actual)
Sponsor
Laval University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

This study aims at determining the patterns of asthma remission, the prevalence of these different patterns, the various factors associated with such remissions and possible recurrences of asthma, in order to determine the mechanisms involved in these processes. The investigators therefore want to document these specificities in subjects in complete remission of their asthma, and those in only symptomatic remission of their asthma, in comparison with mildly symptomatic asthmatic subjects and healthy controls.

Detailed description

Primary Outcome Measures : * Airway inflammation (% induced sputum eosinophils) Secondary Outcome Measures: * Perception of induced respiratory symptoms * Airway response to methacholine and AMP, and perception scores * Diurnal variation in Peak Expiratory Flows * Profile of regulatory T cells in the peripheral blood * Changes in these parameters over time (baseline, 6 months, 1 and 2 years)

Conditions

Timeline

Start date
2007-09-01
Primary completion
2011-06-01
Completion
2012-02-01
First posted
2007-09-06
Last updated
2012-02-22

Source: ClinicalTrials.gov record NCT00526019. Inclusion in this directory is not an endorsement.